• Upon completion of this CME activity, participants should be able to summarize the clinical and paraclinical features of paraneoplastic diseases and cancer related autoimmunity.
  • Upon completion of this CME activity, participants should be able to apply knowledge on management and treatment of paraneoplastic/ autoimmune neurological diseases or neurotoxicity from cancer immuno-oncologic therapies.
  • Upon completion of this CME activity, participants should be able to summarize the impact of immune checkpoint inhibitors and CAR-T on paraneoplastic/autoimmune neurological diseases and potential treatment options.
Session date: 
06/15/2026 - 4:00pm to 5:00pm CDT
Location: 
In-person and Virtually
1685 Highland Ave
MFCB-Room 1220
United States
See map: Google Maps
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
Add to calendar: 
Please login or register to take this course.
Discloser List CME Internal Report